Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-19

Clinical Trial Update: Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating NVN1000 topical gel and vehicle for moderate to severe acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NVN1000 topical gel

Snippet

Sponsor: Novan, Inc. | Conditions: Acne Vulgaris, Acne | Phase 1, Phase 2 | Status: COMPLETED